| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $26,610,587 ) (Continued on the next page) |
| | 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01HD100635 | PREVENTING MATERNAL MORTALITY FROM OBSTRUCTED LABOR | 000 | 4 | NIH | 4/2/2024 | $436,942 |
| | 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01CA252720 | Reposition and Optimization of Deferiprone for Breast Cancer Therapy | 001 | 4 | NIH | 4/16/2024 | $23,679 |
| | 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01CA252720 | Reposition and Optimization of Deferiprone for Breast Cancer Therapy | 000 | 4 | NIH | 3/11/2024 | $426,210 |
| | 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R37CA239039 | "Transcranial FUS therapy with closed-loop US image guidance and circulating tumor DNA | 000 | 5 | NIH | 4/15/2024 | $355,482 |
| | 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01AI148740 | Altering Hepatitis B Virus assembly through pharmacological intervention | 000 | 5 | NIH | 4/19/2024 | $393,060 |
| | 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R35GM136404 | Molecular Tools to Illuminate Copper Transport and Homeostasis | 000 | 5 | NIH | 3/15/2024 | $346,604 |
| | 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01GM136892 | Coordinated Actin Regulation in Directed Neural Crest Cell Migration | 000 | 5 | NIH | 4/10/2024 | $278,789 |
| | 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01MH119189 | Uncovering the Architecture of Metacognition | 000 | 4 | NIH | 3/11/2024 | $332,995 |
| | 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01CA247484 | Lymph node-targeted multistage chemoimmunotherapy for lymphoma | 001 | 5 | NIH | 4/16/2024 | $24,048 |
| | 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01CA247484 | Lymph node-targeted multistage chemoimmunotherapy for lymphoma | 000 | 5 | NIH | 3/11/2024 | $432,839 |
| | 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01CA240476 | Development and application of non-thermal high frequency IRE to treat hepatic tumors | 001 | 5 | NIH | 3/11/2024 | $411,633 |
| | 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01CA240476 | Development and application of non-thermal high frequency IRE to treat hepatic tumors | 002 | 5 | NIH | 3/19/2024 | $0 |
| | 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01HL143450 | Integrative High-Resolution Experimental and Multiscale Modeling of Arrhythmias to Optimize Low Energy Anti-fibrillation Pacing (LEAP) | 000 | 5 | NIH | 3/29/2024 | $493,552 |
| | 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R35GM124871 | Olfactory receptor-based sensors for biomedical applications | 001 | 7 | NIH | 4/4/2024 | $330,749 |
| | 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01GM118803 | Effective MS-Based Methods for Unraveling Cell Surface Protein Interactions | 000 | 7 | NIH | 4/11/2024 | $313,717 |
| | 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R35GM118039 | Interplay of inherent promiscuity and specificity in protein biochemical function with applications to drug discovery and exome analysis | 000 | 9 | NIH | 4/11/2024 | $441,862 |
| | 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01EY021205 | Characterization of purified myocilin: glaucoma as a protein misfolding disease | 000 | 13 | NIH | 4/15/2024 | $400,952 |
| | 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R00EY032603 | Towards a computationally precise characterization of the human ventral visual pathway | 000 | 3 | NIH | 3/14/2024 | $249,080 |
| | 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R03HS029422 | Design, Analysis, and Optimization of Equitable and Value-based Baseline Testing Policies for Sports-Related Concussion | 000 | 2 | AHRQ | 3/22/2024 | $44,264 |
| | 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01HL173002 | Interoceptors controlling airway constriction | 000 | 1 | NIH | 3/20/2024 | $450,678 |
| | 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01HL173943 | Lymphedema therapy via lymphatic targeted drug delivery | 000 | 1 | NIH | 4/1/2024 | $664,892 |
| | 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01HD113598 | Personalized Hip vs Ankle Exoskeleton Assistance with Biofeedback to Enhance Mobility Post-Stroke | 001 | 1 | NIH | 4/15/2024 | $0 |
| | 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01HD113598 | Personalized Hip vs Ankle Exoskeleton Assistance with Biofeedback to Enhance Mobility Post-Stroke | 000 | 1 | NIH | 3/28/2024 | $562,054 |
| | 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | AY2AX000006 | Mapping the Cancer and Organ Degradome Atlas (CODA) to Unlock Synthetic Biomarkers for Multi-Cancer Early Detection | 002 | 1 | NIH | 3/29/2024 | $10,875,289 |
| | 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R35GM152245 | Integrative predictive medicine to identify disease causes, develop cures, and optimize patient care | 000 | 1 | NIH | 4/15/2024 | $366,688 |
| | 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | 2401GAATSG | FY2024 (ATSG) AT Act State Grants for Assistive Technology | 2 | 1 | ACL | 3/15/2024 | $96,524 |
| | 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | 2401GAATSG | FY2024 (ATSG) AT Act State Grants for Assistive Technology | 0 | 1 | ACL | 10/30/2023 | $94,505 |
| | 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | 2401GAATSG | FY2024 (ATSG) AT Act State Grants for Assistive Technology | 1 | 1 | ACL | 12/12/2023 | $151,670 |
| | 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | K22AI173181 | Protective impacts of commensal protists on the human gut microbiome | 000 | 1 | NIH | 3/22/2024 | $156,586 |
| | 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | F31HL174122 | Investigating the Effectiveness and Mechanisms of Lymphaticovenous Anastomoses (LVA) for Lymphedema Treatment: Integrating Computational Modeling with Clinical LVA Insights | 000 | 1 | NIH | 3/18/2024 | $47,694 |
| | 2024 | 2024 | GEORGIA TECH RESEARCH CORPORATION | 926 DALNEY ST NW | ATLANTA | GA | 30332 | FULTON | USA | R01AR082523 | Damage Modeling and Vascular Imaging Correlation with Implant Induced Skin Necrosis | 000 | 1 | NIH | 2/21/2024 | $584,081 |
| | 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | F32EY036268 | The Structural and Biochemical Effects of XFG-Associated Variants in LOXL1 | 000 | 1 | NIH | 3/18/2024 | $69,500 |
| | 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | F31HL174122 | Investigating the Effectiveness and Mechanisms of Lymphaticovenous Anastomoses (LVA) for Lymphedema Treatment: Integrating Computational Modeling with Clinical LVA Insights | 001 | 1 | NIH | 3/18/2024 | $0 |
| | 2024 | 2024 | GEORGIA TECH RESEARCH CORPORATION | 926 DALNEY ST NW | ATLANTA | GA | 30332 | FULTON | USA | R00EB033580 | Machine Perception Nanosensor Array Platform to Capture Whole Disease Fingerprints of Early Stage Pancreatic Cancer | 000 | 3 | NIH | 12/4/2023 | $249,000 |
| | 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | F31HL174133 | Engineering 3D microtissues of pulmonary fibrosis. | 000 | 1 | NIH | 3/22/2024 | $47,694 |
| | 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R35GM153457 | Domesticating and Mapping Interactions of the Human Gastrointestinal Microbiome | 000 | 1 | NIH | 3/25/2024 | $372,051 |
| | 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R35GM150870 | Molecular analysis of bacterial interactions | 000 | 2 | NIH | 4/9/2024 | $336,377 |
| | 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | U01CA280984 | Dysregulated mechanoimmunology of epigenetics-driven lymphomas | 000 | 2 | NIH | 4/15/2024 | $492,169 |
| | 2024 | 2024 | GEORGIA TECH RESEARCH CORPORATION | 926 DALNEY ST NW | ATLANTA | GA | 30332 | FULTON | USA | R21AG081715 | Tissue systems biology of immune dysregulation in aging by single cell spatial metabolomics | 000 | 2 | NIH | 2/9/2024 | $157,815 |
| | 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | K99NS126576 | Plasticity of spinal neural networks directly impacts motor control following peripheral nerve injury | 000 | 2 | NIH | 4/9/2024 | $102,784 |
| | 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R21HD110918 | Functional screen for genetic causes of hypoplastic left heart syndrome | 000 | 2 | NIH | 3/26/2024 | $157,815 |
| | 2024 | 2024 | GEORGIA TECH RESEARCH CORPORATION | 926 DALNEY ST NW | ATLANTA | GA | 30332 | FULTON | USA | R01EB034301 | Synthetic biological systems for protein detection | 000 | 2 | NIH | 2/13/2024 | $320,355 |
| | 2024 | 2024 | GEORGIA TECH RESEARCH CORPORATION | 926 DALNEY ST NW | ATLANTA | GA | 30332 | FULTON | USA | R01AG082039 | Inferring multi-scale dynamics underlying behavior in aging C. elegans | 000 | 2 | NIH | 1/24/2024 | $466,461 |
| | 2024 | 2024 | GEORGIA TECH RESEARCH CORPORATION | 926 DALNEY ST NW | ATLANTA | GA | 30332 | FULTON | USA | R35GM145350 | Illuminating Heme Trafficking and Signaling Pathways in Health and Disease | 000 | 3 | NIH | 2/15/2024 | $337,241 |
| | 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | T32GM145735 | T32 CTEng (Cellular and Tissue Engineering) Training Program | 000 | 3 | NIH | 3/20/2024 | $477,482 |
| | 2024 | 2024 | GEORGIA TECH RESEARCH CORPORATION | 926 DALNEY ST NW | ATLANTA | GA | 30332 | FULTON | USA | R01MH130064 | Modularly built, complete, coordinate- and template-free brain atlases | 000 | 3 | NIH | 1/22/2024 | $578,655 |
| | 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01CA268125 | Mechanisms underlying spontaneous firing by motoneurons with acute neurotoxicity | 001 | 3 | NIH | 4/17/2024 | $24,365 |
| | 2024 | 2024 | GEORGIA TECH RESEARCH CORPORATION | 926 DALNEY ST NW | ATLANTA | GA | 30332 | FULTON | USA | R01CA268125 | Mechanisms underlying spontaneous firing by motoneurons with acute neurotoxicity | 000 | 3 | NIH | 1/15/2024 | $438,569 |
| | 2024 | 2024 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | T32GM142616 | Integrative and Quantitative Biosciences Accelerated Training Environment | 000 | 4 | NIH | 4/3/2024 | $301,431 |
|
